Literature DB >> 8898419

Impairment of antioxidants in colonic epithelial cells isolated from trinitrobenzene sulphonic acid-induced colitis rats. Protective effect of rebamipide.

W L Zea-Iriarte1, K Makiyama, S Goto, K Murase, Y Urata, I Sekine, K Hara, T Kondo.   

Abstract

BACKGROUND: The functional status of glutathione, its related enzymes, and Cu,Zn-superoxide dismutase in colonocytes isolated from rats with trinitrobenzene sulphonic acid-induced colitis, and the effect of rebamipide (a scavenger) on these antioxidants and on colitis, were studied.
METHODS: The rats were treated with rebamipide, killed on day 14, and compared with controls. Glutathione and enzymatic activities were spectrophotometrically estimated. The effect of rebamipide on colitis was also assessed histologically and by myeloperoxidase activity.
RESULTS: In controls the concentration of glutathione and the activities of glutathione S-transferase and Cu,Zn-superoxide dismutase were decreased, but that of glutathione peroxidase was increased. Rebamipide prevented the impairment of these enzymes, restored the concentration of glutathione, and attenuated (low damage scores and myeloperoxidase activity) the severity of the colitis.
CONCLUSIONS: These features suggest that the impairment of antioxidants is closely related to the development of the inflammatory lesions, and rebamipide has a beneficial effect on experimental colitis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8898419     DOI: 10.3109/00365529609003118

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  16 in total

1.  Efficacy of rebamipide enemas in active distal ulcerative colitis and proctitis: a prospective study report.

Authors:  K Makiyama; F Takeshima; T Hamamoto
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

2.  Relation between colonic inflammation severity and total low-molecular-weight antioxidant profiles in experimental colitis.

Authors:  S Blau; R Kohen; P Bass; A Rubinstein
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

3.  Novel topical therapies for distal colitis.

Authors:  Ian Craig Lawrance
Journal:  World J Gastrointest Pharmacol Ther       Date:  2010-10-06

4.  Rebamipide enema is effective for treatment of experimental dextran sulfate sodium induced colitis in rats.

Authors:  Takako Nakashima; Takashi Maeda; Hisashi Nagamoto; Takeshi Kumakura; Masaaki Takai; Toyoki Mori
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

5.  Rebamipide, an antiulcer drug, prevents DSS-induced colitis formation in rats.

Authors:  S Kishimoto; K Haruma; A Tari; K Sakurai; M Nakano; Y Nakagawa
Journal:  Dig Dis Sci       Date:  2000-08       Impact factor: 3.199

6.  Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study.

Authors:  Yasumasa Niwa; Masanao Nakamura; Naoki Ohmiya; Osamu Maeda; Takafumi Ando; Akihiro Itoh; Yoshiki Hirooka; Hidemi Goto
Journal:  J Gastroenterol       Date:  2008-05-06       Impact factor: 7.527

7.  The adenosine A2A receptor agonist CGS 21680 fails to ameliorate the course of dextran sulphate-induced colitis in mice.

Authors:  Z Selmeczy; B Csóka; P Pacher; E S Vizi; G Haskó
Journal:  Inflamm Res       Date:  2007-05       Impact factor: 4.575

8.  Analysis of mucosal stress response in acid-induced esophagitis in opossum.

Authors:  Robert J White; Gerald P Morris; Christopher D Moyes; Michael G Blennerhassett; Ceredwyn E Hill; Gail C Pringle; William G Paterson
Journal:  Dig Dis Sci       Date:  2002-08       Impact factor: 3.199

9.  Modulatory effects of plasma and colonic milieu of patients with ulcerative colitis on neutrophil reactive oxygen species production in presence of a novel antioxidant, rebamipide.

Authors:  A Farhadi; A Keshavarzian; L R Fitzpatrick; E Mutlu; Y Zhang; A Banan
Journal:  Dig Dis Sci       Date:  2002-06       Impact factor: 3.199

10.  Rebamipide suppresses TLR-TBK1 signaling pathway resulting in regulating IRF3/7 and IFN-α/β reduction.

Authors:  Naotaka Ogasawara; Makoto Sasaki; Yukimi Itoh; Kentaro Tokudome; Yoshihiro Kondo; Yoshitsugi Ito; Satoshi Tanida; Takeshi Kamiya; Hiromi Kataoka; Takashi Joh; Kunio Kasugai
Journal:  J Clin Biochem Nutr       Date:  2011-02-26       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.